CVS is cutting the price on a generic version of a competitor of the EpiPen allergy treatment.
The drugstore chain announced Thursday that it will sell a generic version of Impax Laboratories (IPXL)' Adrenaclick treatment for $109.99 per two-pack, down from $200.
The drug company Mylan drew the ire of customers and Congress when it raised the price to more than $600 for an EpiPen two-pack. Mylan later announced plans to sell a generic version for $300.
Cigna (CI), a top insurer, announced Wednesday that it was dropping coverage of the EpiPen and would cover only the half-priced generic.
A CVS Health (CVS) spokeswoman said the price cut for the generic Adrenaclick was unrelated.
Related: Drug stocks drop after Trump says they're 'getting away with murder'
Adrenaclick and EpiPen give an emergency injection of epinephrine to treat life-threatening allergic reactions known as anaphylactic shock.
Also on Wednesday, President-elect Donald Trump vowed at a press conference to fight price hikes by drug companies, which he lambasted for "getting away with murder." Mylan (MYL)'s stock price dropped more than 4%.
